ADMA Biologics ADMA State
State at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit.
The official record: ADMA Biologics’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's state.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ADMA Biologics's state?
- ADMA Biologics (ADMA) reported state of $409.25K in Q4 2025.
- How has ADMA Biologics's state changed year-over-year?
- ADMA Biologics's state increased by 114.3% year-over-year, from -$2.86M to $409.25K.
- What does state mean?
- Represents the change in deferred tax assets or liabilities related to state and local income taxes resulting from temporary differences between financial reporting and tax reporting. This metric highlights future tax consequences of current accounting decisions. It provides insight into the timing differences of tax obligations at the sub-national level.